Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
US7858738B2 · kind B2 · utility
0Cited by
13References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 20, 2007 |
| Grant date | Dec 28, 2010 |
| Priority date | — |
| Expiry date | Mar 20, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Synthetic peptides of at least 12 and at most 30 amino acid residues comprising a sequence consisting of, or found within, a complementarity-determining region (CDR) found in the heavy or light chain of the human anti-DNA 16/6Id monoclonal antibody, or a sequence obtained by replacement and/or deletion and/or addition of one or more amino residues to said sequence, and salts, chemical derivatives and polymers of said peptides can be used for immunomodulation of systemic lupus erythematosus-associated responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.